Teva to hire 200 in Jerusalem

Teva Pharmaceuticals Ltd., the world's largest manufacturer of generic drugs, said it will hire 200 new workers for its Jerusalem factory to producing some 8 billion pills a year worth $700m.

By MATTHEW KRIEGER
April 5, 2007 07:29
teva logo 88

teva logo 88. (photo credit: )

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Teva Pharmaceuticals Ltd., the world's largest manufacturer of generic drugs, said Wednesday it will hire 200 new workers for its Jerusalem factory to producing some 8 billion pills a year worth $700 million. The factory, based in Har Hotzvim, Jerusalem's industrial area, has been in operation for about three years and will now be able to manufacture pills to be sold in both the Israeli and US markets after recently receiving approval from the US Food and Drug Administration. "With this approval from the FDA, we will be able to expand our operations and our exports as well as create new jobs in Jerusalem - something which is very important to the company," said Teva's CEO Shlomo Yannai. Over the remainder of 2007, the company expects to produce about 4 billion tablets and plans on doubling this number next year. The factory is one of 38 that Teva has around the world; its construction cost $100m.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS